A detailed history of Pathstone Family Office, LLC transactions in Viatris Inc stock. As of the latest transaction made, Pathstone Family Office, LLC holds 54,306 shares of VTRS stock, worth $629,949. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,306
Previous 23,022 135.89%
Holding current value
$629,949
Previous $229,000 133.62%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$9.59 - $11.35 $300,013 - $355,073
31,284 Added 135.89%
54,306 $535,000
Q2 2023

Jan 12, 2024

SELL
$9.02 - $10.29 $282,127 - $321,850
-31,278 Reduced 57.6%
23,028 $229,000
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $30,379 - $34,656
3,368 Added 17.14%
23,022 $229,000
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $88,172 - $117,499
-9,584 Reduced 32.78%
19,654 $189,000
Q4 2022

Oct 23, 2023

BUY
$8.72 - $11.56 $100,663 - $133,448
11,544 Added 65.24%
29,238 $325,000
Q4 2022

Feb 13, 2023

BUY
$8.72 - $11.56 $40,617 - $53,846
4,658 Added 18.95%
29,238 $325,000
Q3 2022

Oct 23, 2023

SELL
$8.48 - $11.13 $746 - $979
-88 Reduced 0.49%
17,694 $150,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $13,932 - $18,286
1,643 Added 7.16%
24,580 $220,000
Q2 2022

Oct 23, 2023

SELL
$9.95 - $12.27 $52,137 - $64,294
-5,240 Reduced 22.76%
17,782 $186,000
Q2 2022

Aug 15, 2022

BUY
$9.95 - $12.27 $228,223 - $281,436
22,937 New
22,937 $238,000
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $121,018 - $165,098
-8,905 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $127,341 - $166,879
8,905 New
8,905 $167,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.